Market Cap 366.06M
Revenue (ttm) 0.00
Net Income (ttm) -78.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 160,500
Avg Vol 231,476
Day's Range N/A - N/A
Shares Out 36.50M
Stochastic %K 23%
Beta N/A
Analysts Strong Sell
Price Target $37.33

Latest News on RAPP

Rapport semestriel Pilier 3 - 30 juin 2024

Sep 17, 2024, 2:35 AM EDT - 7 months ago

Rapport semestriel Pilier 3 - 30 juin 2024


J&J-backed Rapport Therapeutics raises $136 mln in US IPO

Jun 6, 2024, 7:57 PM EDT - 10 months ago

J&J-backed Rapport Therapeutics raises $136 mln in US IPO

JNJ


Rapport Therapeutics Seeks IPO For CNS Treatment Programs

May 22, 2024, 4:17 PM EDT - 11 months ago

Rapport Therapeutics Seeks IPO For CNS Treatment Programs


J&J-backed startup Rapport files for US IPO

May 17, 2024, 6:07 PM EDT - 11 months ago

J&J-backed startup Rapport files for US IPO


Rapport Therapeutics IPO Registration Document (S-1)

May 17, 2024, 4:02 PM EDT - 11 months ago

Rapport Therapeutics IPO Registration Document (S-1)